Sign inGet started

BIGHAM MICHAEL

Insider CIK 1216917 · PRTK Exec. Chairman of the Board, Director · ADMS Director · SUPN Director · FLAC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PRTK Paratek Pharmaceuticals, I D To issuer2023-09-212023-09-21228,750— $00SEC↗
PRTK Paratek Pharmaceuticals, I D To issuer2023-09-212023-09-211,129,282— $0228,750SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2023-08-092023-08-1031,250$2.20 $68.8K1,334,702SEC↗
PRTK Paratek Pharmaceuticals, I A Award2023-08-082023-08-10156,250— $01,365,952SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2022-12-212022-12-2215,750$1.99 $31.3K1,209,702SEC↗
PRTK Paratek Pharmaceuticals, I A Award2022-12-202022-12-2245,000— $01,225,452SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2022-12-132022-12-1431,891$1.96 $62.5K1,180,452SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2022-12-122022-12-1419,484$1.98 $38.6K1,212,343SEC↗
FLAC Frazier Lifesciences Acqui M Exercise deriv2022-11-222022-11-2330,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2022-10-282022-11-016,000$3.47 $20.8K1,231,827SEC↗
PRTK Paratek Pharmaceuticals, I A Award2022-10-252022-10-2730,000— $01,237,827SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2022-08-092022-08-1028,637$2.66 $76.2K1,207,827SEC↗
PRTK Paratek Pharmaceuticals, I A Award2022-08-082022-08-10143,182— $01,236,464SEC↗
PRTK Paratek Pharmaceuticals, I A Award2022-03-152022-03-23202,500— $01,093,282SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2021-12-152021-12-1517,819$4.27 $76.1K890,782SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2021-12-142021-12-158,622$4.37 $37.7K908,601SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2021-12-132021-12-155,059$4.42 $22.4K917,223SEC↗
ADMS Adamas Pharmaceuticals Inc D To issuer deriv2021-11-242021-11-2410,000— $00SEC↗
ADMS Adamas Pharmaceuticals Inc D To issuer deriv2021-11-242021-11-2410,000— $00SEC↗
ADMS Adamas Pharmaceuticals Inc D To issuer deriv2021-11-242021-11-2410,000— $00SEC↗
ADMS Adamas Pharmaceuticals Inc U Tender2021-11-242021-11-2410,000— $00SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2021-08-172021-08-1832,030$5.12 $164.0K922,282SEC↗
PRTK Paratek Pharmaceuticals, I A Award2021-08-162021-08-1875,000— $0954,312SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2021-06-042021-06-0834,364$9.70 $333.3K879,312SEC↗
ADMS Adamas Pharmaceuticals Inc A Award deriv2021-06-022021-06-0410,000— $010,000SEC↗
ADMS Adamas Pharmaceuticals Inc A Award2021-06-022021-06-045,000— $010,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2021-05-272021-06-0885,909— $0913,676SEC↗
PRTK Paratek Pharmaceuticals, I A Award2021-03-302021-04-01281,250— $0827,767SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2020-12-142020-12-1526,063$6.71 $174.9K546,517SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2020-12-112020-12-1518,337$6.95 $127.4K572,580SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2020-11-132020-11-1626,250$5.93 $155.7K590,917SEC↗
PRTK Paratek Pharmaceuticals, I A Award2020-11-122020-11-1675,000— $0617,167SEC↗
ADMS Adamas Pharmaceuticals Inc A Award deriv2020-06-032020-06-0510,000— $010,000SEC↗
ADMS Adamas Pharmaceuticals Inc A Award2020-06-032020-06-055,000— $05,000SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2020-05-122020-05-1412,250$4.68 $57.3K542,167SEC↗
PRTK Paratek Pharmaceuticals, I A Award2020-02-192020-02-21135,000— $0554,417SEC↗
PRTK Paratek Pharmaceuticals, I A Award2019-10-042019-10-0828,000— $0419,417SEC↗
ADMS Adamas Pharmaceuticals Inc A Award deriv2019-06-052019-06-0610,000— $010,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2019-02-262019-02-28120,000— $0391,417SEC↗
PRTK Paratek Pharmaceuticals, I A Award2019-02-012019-02-0435,000— $0271,417SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-12-122018-12-148,400$6.76 $56.8K256,467SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-10-152018-10-166,300$8.96 $56.4K264,867SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-10-122018-10-1614,000— $0271,167SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-10-032018-10-0416,313$9.82 $160.2K257,167SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-10-022018-10-0436,250— $0213,480SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-10-022018-10-0460,000— $0273,480SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-07-022018-07-0522,500$9.97 $224.3K177,230SEC↗
PRTK Paratek Pharmaceuticals, I G Gift2018-06-212019-02-0420,050— $0236,417SEC↗
ADMS Adamas Pharmaceuticals Inc A Award deriv2018-06-062018-06-0710,000— $010,000SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-04-092018-04-108,700$12.70 $110.5K199,730SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-04-032018-04-0521,750— $0208,430SEC↗
PRTK Paratek Pharmaceuticals, I A Award2018-02-142018-02-1663,000— $0186,680SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2018-02-052018-02-074,000$14.22 $56.9K123,680SEC↗
PRTK Paratek Pharmaceuticals, I M Exercise deriv2018-02-022023-09-2123,225— $00SEC↗
PRTK Paratek Pharmaceuticals, I M Exercise2018-02-022023-09-2123,255$4.30 $100.0K1,358,032SEC↗
PRTK Paratek Pharmaceuticals, I M Exercise deriv2017-07-192017-07-2123,255— $0121,838SEC↗
PRTK Paratek Pharmaceuticals, I M Exercise2017-07-192017-07-2123,255$4.30 $100.0K127,680SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-07-052017-07-065,075$23.58 $119.7K104,425SEC↗
PRTK Paratek Pharmaceuticals, I A Award2017-07-032017-07-0614,500— $0109,500SEC↗
ADMS Adamas Pharmaceuticals Inc A Award deriv2017-06-012017-06-0215,000— $015,000SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-0832$15.08 $48396,752SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-0830$15.20 $45699,970SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-082,104$15.10 $31.8K96,784SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-081,082$15.15 $16.4K98,888SEC↗
PRTK Paratek Pharmaceuticals, I S Sale2017-02-062017-02-081,752$15.05 $26.4K95,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2017-02-022017-02-0672,500— $072,500SEC↗
ADMS Adamas Pharmaceuticals Inc A Award deriv2016-09-202016-09-2230,000— $030,000SEC↗
PRTK Paratek Pharmaceuticals, I P Buy2016-06-232016-06-2720,000$13.45 $269.0K100,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2016-02-042016-02-0860,000— $060,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2016-02-042016-02-0830,000— $080,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award deriv2015-06-302015-07-02100,000— $0100,000SEC↗
PRTK Paratek Pharmaceuticals, I A Award2015-06-302015-07-0250,000— $050,000SEC↗
PRTK Paratek Pharmaceuticals, I J Other deriv2015-02-042015-02-06145,093— $0145,093SEC↗
PRTK Paratek Pharmaceuticals, I J Other deriv2015-02-042015-02-06145,093— $0145,093SEC↗
PRTK Paratek Pharmaceuticals, I J Other deriv2014-10-302014-11-03145,093— $0145,093SEC↗
PRTK Paratek Pharmaceuticals, I J Other deriv2014-10-302014-11-03145,093— $0290,186SEC↗
PRTK Paratek Pharmaceuticals, I J Other deriv2014-10-302014-11-03145,093— $0435,279SEC↗
PRTK Paratek Pharmaceuticals, I J Other2014-10-302014-11-031,301,413— $01,301,413SEC↗
SUPN SUPERNUS PHARMACEUTICALS I P Buy2013-03-222013-03-2615,000$5.65 $84.8K25,000SEC↗
SUPN SUPERNUS PHARMACEUTICALS I P Buy2013-03-202013-03-265,000$5.17 $25.9K5,000SEC↗
SUPN SUPERNUS PHARMACEUTICALS I P Buy2013-03-202013-03-265,000$5.20 $26.0K5,000SEC↗
SUPN SUPERNUS PHARMACEUTICALS I P Buy2013-03-202013-03-2610,000$5.26 $52.6K10,000SEC↗
SUPN SUPERNUS PHARMACEUTICALS I A Award deriv2013-02-052013-02-078,722— $08,722SEC↗